Atlas Trials

An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease

Clinical trial NCT02271347 · WITHDRAWN

Trial details

NCT number
NCT02271347
Sponsor
Jazz Pharmaceuticals
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ebola Virus
Start date
2014-10-01
Primary completion
2015-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.